BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4043905)

  • 21. [Hypo-sensitization by oral administration of aqueous pollen extracts].
    Fargetton B; Blandin G; Latil F
    Allerg Immunol (Paris); 1987 Apr; 19(4):165-6. PubMed ID: 3453133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinico-immunological characteristics of peroral specific hyposensitization in hay fevers in children].
    Kats PD; Ostroumov AI; Ametov AS; Iusuf-Zade LI; Toritsina LK
    Pediatriia; 1985 Aug; (8):18-21. PubMed ID: 4069876
    [No Abstract]   [Full Text] [Related]  

  • 23. Sublingual immunotherapy.
    Corrigan C
    J Allergy Clin Immunol; 2007 Feb; 119(2):515; author reply 515-7. PubMed ID: 17187850
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diagnosis and specific hyposensitization of pollen rhinopathy (hay fever)].
    Ushakova TA; Titova SM
    Vestn Otorinolaringol; 1973; 35(1):25-8. PubMed ID: 4781543
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukocyte histamine release and humoral changes during oral and subcutaneous hyposensitization of grass pollen allergic children.
    Wahn U; Maasch HJ; Geissler W
    Helv Paediatr Acta; 1984 May; 39(2):137-44. PubMed ID: 6085730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hay fever. Discussion of an approach to more comprehensive treatment.
    Bickmore JT
    Ohio State Med J; 1972 Sep; 68(9):851-4. PubMed ID: 4637373
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oral hyposensitization (author's transl)].
    Ebner H
    Wien Klin Wochenschr Suppl; 1980; 117():19-21. PubMed ID: 6936977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peroral specific hyposensitization in ambrosia-induced pollinosis].
    Mikhaĭlov EL
    Sov Med; 1976; (5):110-3. PubMed ID: 968591
    [No Abstract]   [Full Text] [Related]  

  • 29. The significance of testing and hyposensitization with several grass pollens for hay fever.
    Heijer A; Göransson K
    Acta Allergol; 1968 May; 23(2):146-60. PubMed ID: 5755560
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies in pollen allergy. 3. The relationship between blocking antibody levels and symptomatic relief following hyposensitisation with allpyral in hay fever subjects.
    Starr MS; Weinstock M
    Int Arch Allergy Appl Immunol; 1970; 38(5):514-21. PubMed ID: 4191851
    [No Abstract]   [Full Text] [Related]  

  • 31. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
    Novembre E; Galli E; Landi F; Caffarelli C; Pifferi M; De Marco E; Burastero SE; Calori G; Benetti L; Bonazza P; Puccinelli P; Parmiani S; Bernardini R; Vierucci A
    J Allergy Clin Immunol; 2004 Oct; 114(4):851-7. PubMed ID: 15480326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunological and clinical studies on the pollen-L-tyrosin complexes in hyposensitization therapy].
    Horak F
    Wien Med Wochenschr; 1977 Nov; 127(22):677-81. PubMed ID: 595610
    [No Abstract]   [Full Text] [Related]  

  • 33. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 34. Maintenance immunotherapy in ragweed hay fever. Booster injections at six week intervals.
    Norman PS; Winkenwerder WL; Lichtenstein LM
    J Allergy; 1971 May; 47(5):273-82. PubMed ID: 4102487
    [No Abstract]   [Full Text] [Related]  

  • 35. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 36. Pollen challenge study of a phototherapy device for reducing the symptoms of hay fever.
    Emberlin JC; Lewis RA
    Curr Med Res Opin; 2009 Jul; 25(7):1635-44. PubMed ID: 19476405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative characteristics of the effectiveness of specific treatment methods in seasonal allergic rhinosinusitis].
    Giusan AO; Raĭkis BN
    Vestn Otorinolaringol; 1980; (3):50-2. PubMed ID: 6992395
    [No Abstract]   [Full Text] [Related]  

  • 38. Monoid sublingual immunotherapy.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
    Ohashi Y
    Arerugi; 2008 May; 57(5):519-23. PubMed ID: 18520172
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oral desensitization in children].
    Wortmann F
    Allerg Asthma (Leipz); 1965; 11(3):118-23. PubMed ID: 5867104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.